Allogeneic Hematopoietic Stem-Cell Transplant Recipients and Skin Cancer Risk: A Commercial Claims Cohort Study. Mohr C, Li Y, Navsaria LJ, Hinkston CL, et al. J Invest Dermatol 2025 Jan 9:S0022-202X(25)00002.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mohr C, Li Y, Navsaria LJ, Hinkston CL, et al. Allogeneic Hematopoietic Stem-Cell Transplant Recipients and Skin Cancer Risk: A Commercial Claims Cohort Study. J Invest Dermatol 2025 Jan 9:S0022-202X(25)00002.
PMID: 39798785